[
    {
        "id": "1",
        "drugA": "Warfarin",
        "drugB": "Aspirin",
        "severity": "severe",
        "description": "Increased risk of bleeding and bruising",
        "mechanism": "Additive anticoagulant effect - both drugs inhibit platelet function",
        "management": "Avoid combination. If necessary, monitor INR closely and watch for bleeding signs",
        "evidenceLevel": "Well-established",
        "clinicalSignificance": "Highly clinically significant"
    },
    {
        "id": "2",
        "drugA": "Warfarin",
        "drugB": "Ibuprofen",
        "severity": "severe",
        "description": "Increased risk of gastrointestinal bleeding",
        "mechanism": "NSAIDs inhibit prostaglandins that protect gastric mucosa + potentiate warfarin effect",
        "management": "Use alternative analgesic. If unavoidable, monitor INR and use gastric protection",
        "evidenceLevel": "Well-established",
        "clinicalSignificance": "Highly clinically significant"
    },
    {
        "id": "3",
        "drugA": "Simvastatin",
        "drugB": "Clarithromycin",
        "severity": "severe",
        "description": "Increased risk of myopathy and rhabdomyolysis",
        "mechanism": "Clarithromycin inhibits CYP3A4 metabolism of simvastatin",
        "management": "Avoid combination. Use alternative statin or antibiotic",
        "evidenceLevel": "Well-established",
        "clinicalSignificance": "Highly clinically significant"
    },
    {
        "id": "4",
        "drugA": "Digoxin",
        "drugB": "Furosemide",
        "severity": "moderate",
        "description": "Risk of digoxin toxicity due to hypokalemia",
        "mechanism": "Furosemide causes potassium loss which sensitizes myocardium to digoxin",
        "management": "Monitor potassium levels regularly. Maintain potassium >4.0 mEq/L",
        "evidenceLevel": "Well-established",
        "clinicalSignificance": "Clinically significant"
    },
    {
        "id": "5",
        "drugA": "Metformin",
        "drugB": "Contrast Media",
        "severity": "severe",
        "description": "Risk of lactic acidosis",
        "mechanism": "Contrast media impair renal function leading to metformin accumulation",
        "management": "Stop metformin 48 hours before and after contrast procedure",
        "evidenceLevel": "Well-established",
        "clinicalSignificance": "Highly clinically significant"
    },
    {
        "id": "6",
        "drugA": "ACE Inhibitors",
        "drugB": "Potassium-Sparing Diuretics",
        "severity": "moderate",
        "description": "Risk of hyperkalemia",
        "mechanism": "Both drugs reduce potassium excretion",
        "management": "Monitor potassium levels. Avoid potassium supplements",
        "evidenceLevel": "Well-established",
        "clinicalSignificance": "Clinically significant"
    },
    {
        "id": "7",
        "drugA": "SSRIs",
        "drugB": "NSAIDs",
        "severity": "moderate",
        "description": "Increased risk of gastrointestinal bleeding",
        "mechanism": "SSRIs inhibit platelet serotonin uptake, NSAIDs inhibit prostaglandins",
        "management": "Use with caution. Consider gastric protection with PPI",
        "evidenceLevel": "Well-established",
        "clinicalSignificance": "Clinically significant"
    },
    {
        "id": "8",
        "drugA": "Beta Blockers",
        "drugB": "Calcium Channel Blockers",
        "severity": "moderate",
        "description": "Additive bradycardia and hypotension",
        "mechanism": "Both drugs depress SA and AV node function",
        "management": "Monitor heart rate and blood pressure. Start with low doses",
        "evidenceLevel": "Well-established",
        "clinicalSignificance": "Clinically significant"
    },
    {
        "id": "9",
        "drugA": "Levothyroxine",
        "drugB": "Calcium Carbonate",
        "severity": "moderate",
        "description": "Decreased levothyroxine absorption",
        "mechanism": "Calcium binds levothyroxine in GI tract",
        "management": "Administer levothyroxine 4 hours before or after calcium",
        "evidenceLevel": "Well-established",
        "clinicalSignificance": "Clinically significant"
    },
    {
        "id": "10",
        "drugA": "Oral Contraceptives",
        "drugB": "Antibiotics",
        "severity": "mild",
        "description": "Potential decreased contraceptive efficacy",
        "mechanism": "Antibiotics may alter gut flora affecting enterohepatic recycling",
        "management": "Use backup contraception during antibiotic therapy",
        "evidenceLevel": "Theoretical",
        "clinicalSignificance": "Moderately significant"
    },
    {
        "id": "11",
        "drugA": "Warfarin",
        "drugB": "Omeprazole",
        "severity": "moderate",
        "description": "Potential increased warfarin effect",
        "mechanism": "Omeprazole inhibits CYP2C19 which may affect warfarin metabolism",
        "management": "Monitor INR when starting or stopping omeprazole",
        "evidenceLevel": "Moderate",
        "clinicalSignificance": "Clinically significant"
    },
    {
        "id": "12",
        "drugA": "Statins",
        "drugB": "Grapefruit Juice",
        "severity": "moderate",
        "description": "Increased statin levels and toxicity risk",
        "mechanism": "Grapefruit inhibits CYP3A4 metabolism of statins",
        "management": "Avoid large quantities of grapefruit juice with statins",
        "evidenceLevel": "Well-established",
        "clinicalSignificance": "Clinically significant"
    },
    {
        "id": "13",
        "drugA": "Lithium",
        "drugB": "NSAIDs",
        "severity": "severe",
        "description": "Increased lithium levels and toxicity risk",
        "mechanism": "NSAIDs reduce renal lithium clearance",
        "management": "Avoid combination. Monitor lithium levels if used together",
        "evidenceLevel": "Well-established",
        "clinicalSignificance": "Highly clinically significant"
    },
    {
        "id": "14",
        "drugA": "MAOIs",
        "drugB": "SSRIs",
        "severity": "severe",
        "description": "Risk of serotonin syndrome",
        "mechanism": "Additive serotonin enhancement",
        "management": "Absolute contraindication. Allow 2-week washout period",
        "evidenceLevel": "Well-established",
        "clinicalSignificance": "Highly clinically significant"
    },
    {
        "id": "15",
        "drugA": "Warfarin",
        "drugB": "Vitamin K",
        "severity": "moderate",
        "description": "Decreased warfarin anticoagulant effect",
        "mechanism": "Vitamin K antagonizes warfarin's effect",
        "management": "Maintain consistent vitamin K intake. Monitor INR",
        "evidenceLevel": "Well-established",
        "clinicalSignificance": "Clinically significant"
    }
]